EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

G0S2 Promotes PD-L1 Expression in Monocytes and Influences the Efficacy of PD-1 Inhibitors in Hepatocellular Carcinoma

Xuanshuang Du, Wenwen Zhang, Sujuan Sun, Chenghao Liu, Yuanying He, Fengling Luo, Hongyan Wu iD, Min Liu iD

Genes · 2025

DOI: 10.3390/genes16040448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Xuanshuang Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, B7-H1 Antigen, Monocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China grants, National Natural Science Foundation of China, Natural Science Foundation Project of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is a prevalent and highly lethal form of liver cancer, with limited effective treatment options, particularly in the advanced stages. Immunotherapy using PD-1 inhibitors has emerged as a promising treatment modality, yet a substantial proportion of patients exhibit resistance or fail to respond to such therapies. This study aimed to elucidate the role of G0/G1 Switch 2 (G0S2) in regulating PD-L1 expression in monocytes within the HCC tumor microenvironment and to investigate its impact on the efficacy of PD-1 inhibitors.

Methods

Gene expression data among HCC patients treated with PD-1 inhibitors were obtained from the HCC single-cell sequencing database; immunohistochemistry was performed to detect G0S2 expression in liver cancer tissues and adjacent non-tumorous tissues of HCC patients; flow cytometry was utilized to analyze the expression of G0S2, PD-L1, CD206, and CD14 in PBMCs from HCC patients; and CD8+T cell proliferation and IFN-γ secretion were used to evaluate the impact of G0S2 knockdown.

Results

Utilizing single-cell sequencing data from HCC patients, we identified that G0S2 expression was significantly elevated in the non-responders (NR) compared to responders (R) to PD-1 inhibitor therapy. The immunohistochemical analysis confirmed higher levels of G0S2 in HCC tumor tissues and adjacent non-tumorous tissues, while the flow cytometry revealed the increased expression of G0S2, PD-L1, and CD206 in peripheral blood mononuclear cells (PBMCs) from NR patients compared to R patients and healthy controls. The functional experiments involving the knockdown of G0S2 in the THP-1 monocyte cell line resulted in a significant reduction in PD-L1 expression and a concomitant increase in CD8+T cell proliferation and IFN-γ production.

Conclusions

These findings indicate that G0S2 facilitates the upregulation of PD-L1 in monocytes, thereby suppressing T cell activity and contributing to resistance against PD-1 inhibitors in HCC. The high expression of G0S2 in peripheral blood monocytes offers a non-invasive and easily detectable biomarker for predicting the efficacy of PD-1 inhibitor therapy. Consequently, targeting G0S2 may enhance the responsiveness to immunotherapy in HCC patients, providing a new avenue for optimizing treatment strategies and improving patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsB7-H1 AntigenMonocytesImmune Checkpoint InhibitorsHumansTumor MicroenvironmentMaleGene Expression Regulation, NeoplasticFemaleProgrammed Cell Death 1 ReceptorCD8-Positive T-LymphocytesMiddle AgedCell Proliferation

Stichwörter der Autor:innen

G0S2PD-1 inhibitorsPD-L1T cell responsehepatocellular carcinoma

Substanzen

B7-H1 AntigenCD274 protein, humanImmune Checkpoint InhibitorsProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Department of Immunology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan 430071, China.
  • Department of Pathology, TaiKang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan 430071, China.
  • Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China.
  • College of Basic Medicine, China Three Gorges University, Yichang 443002, China.

ORCID-Profile: Hongyan Wu, Min Liu

Förderung

  • National Natural Science Foundation of China grants
  • National Natural Science Foundation of China
  • Natural Science Foundation Project of Hubei Province
  • Open Foundation of Hubei Province Key Laboratory of Tumor Microenvironment and Immunotherapy

Zitieren

APA

Du, X., Zhang, W., Sun, S., Liu, C., He, Y., Luo, F., Wu, H., & Liu, M. (2025). G0S2 Promotes PD-L1 Expression in Monocytes and Influences the Efficacy of PD-1 Inhibitors in Hepatocellular Carcinoma. Genes. https://doi.org/10.3390/genes16040448

Vancouver

Du X, Zhang W, Sun S, Liu C, He Y, Luo F, et al. G0S2 Promotes PD-L1 Expression in Monocytes and Influences the Efficacy of PD-1 Inhibitors in Hepatocellular Carcinoma. Genes. 2025. doi:10.3390/genes16040448

BibTeX
@article{Du2025,
  author = {Du, Xuanshuang and Zhang, Wenwen and Sun, Sujuan and Liu, Chenghao and He, Yuanying and Luo, Fengling and Wu, Hongyan and Liu, Min},
  title = {G0S2 Promotes PD-L1 Expression in Monocytes and Influences the Efficacy of PD-1 Inhibitors in Hepatocellular Carcinoma},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16040448}
}
Kostenlos starten →